| Jacey Zoe Shumaker, MS, CCC-SLP | |
|
77 Warren St, Building 4, Brighton, MA 02135-3601 | |
| (617) 930-1370 | |
| Not Available |
| Full Name | Jacey Zoe Shumaker |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 77 Warren St, Brighton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457409658 | NPI | - | NPPES |
| SP0118 | Other | MA | BCBS PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 4737 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacey Zoe Shumaker, MS, CCC-SLP 41 Hartford St, Natick, MA 01760-2402 Ph: (617) 930-1370 | Jacey Zoe Shumaker, MS, CCC-SLP 77 Warren St, Building 4, Brighton, MA 02135-3601 Ph: (617) 930-1370 |
News Archive
The way the human brain works remains, to a great extent, a topic of controversy. One reason is our limited ability to study neuronal processes at the level of single cells and capillaries across the entire living brain without employing highly invasive surgical methods. This limitation is now on the brink of change.
For the first time novel expression sites in the brain have been identified for a gene which is associated with Motor Neuron Disease and Frontotemporal Dementia.
Researchers have developed a series of machine learning models that can predict a patient's risk of infection by C. difficile, a gastrointestinal pathogen.
deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University of Iceland reported today in the journal Nature the identification of a rare nonsense mutation that confers high risk of osteoporosis and osteoporosis related traits.
University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments.
› Verified 7 days ago
Ms. Margaret Arcuni Huber, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 736 Cambridge St, Brighton, MA 02135 Phone: 617-562-7735 | |
Sara Elizabeth Gardner, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 242 Corey Rd, Brighton, MA 02135 Phone: 203-241-1926 | |
Julia Martine Rifkin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Viktoriya Berdichevsky, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-254-3800 | |
Mrs. Svetlana Piliavsky, MED-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 170 Corey Rd, Brighton, MA 02135 Phone: 617-383-6624 | |
Mrs. Aliza Zissel Schwab, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 19 Portina Rd, Brighton, MA 02135 Phone: 516-640-0882 | |
Jennifer S Bartecchi, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Warren St, Brighton, MA 02135 Phone: 617-779-1626 |